A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

580

Participants

Timeline

Start Date

June 27, 2022

Primary Completion Date

May 15, 2026

Study Completion Date

December 30, 2026

Conditions
Calcific Aortic Valve Disease
Interventions
DRUG

Evogliptin

DA-1229 10 mg, 1 tab

DRUG

Placebo

DA-1229 Placebo, 1 tab

Trial Locations (25)

10025

RECRUITING

Ichan School of Medicine, New York

11974

RECRUITING

Stony brook, Stony Brook

17050

RECRUITING

University of Pittsburgh Medical Center, Mechanicsburg

19141

RECRUITING

Einstein Medical Center Philadelphia, Philadelphia

22042

RECRUITING

Inova Health Care Services, Falls Church

30342

RECRUITING

Northside Hospital, Atlanta

32224

RECRUITING

Mayo Clinic, FL, Jacksonville

34695

RECRUITING

Baycare Health systems, Safety Harbor

43214

RECRUITING

OhioHealth Research Institute, Columbus

45219

RECRUITING

Christ Hospital, Cincinnati

48073

RECRUITING

Beaumont Hospital, Royal Oak, Royal Oak

48109

RECRUITING

University of Michigan, Ann Arbor

48202

RECRUITING

Henry Ford Health System, Detroit

53215

RECRUITING

Aurora Research Institute, Milwaukee

55905

RECRUITING

Mayo Clinic, Rochester

77030

RECRUITING

Texas Heart Institute, Houston

80045

RECRUITING

University of Colorado, Aurora

85054

RECRUITING

Mayo Clinic, AZ, Phoenix

90033

RECRUITING

University of Southern California, Los Angeles

97239

RECRUITING

Oregon Health & Science University, Portland

02114

RECRUITING

Massachusetts General Hospital, Boston

07601

RECRUITING

Hackensack Meridian Health, Hackensack

08901

RECRUITING

Rutgers- Robert Wood Johnson Medical School, New Brunswick

05401

RECRUITING

The University of Vermont Medical Center, Burlington

Unknown

NOT_YET_RECRUITING

Institut Universitaire de Cardiologie et de Pneumologie de Québec - Université Laval, Québec

All Listed Sponsors
lead

REDNVIA Co., Ltd.

INDUSTRY